Loading clinical trials...
Loading clinical trials...
Viruses with high mutation rates, such influenza or HIV, pose a major challenge for vaccine design. The current influenza vaccination strategy of yearly vaccination with adapted strains aims to maxima...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Hospital, Basel, Switzerland
Collaborators
NCT06148025 · Vaccine Response Impaired
NCT05060991 · COVID-19, Immunosuppression, and more
NCT05116748 · COVID-19, Vaccine Adverse Reaction, and more
NCT05791851 · HIV Infections, Hepatitis B, and more
NCT03855176 · Hepatitis A, Human Immunodeficiency Virus, and more
University Hospital Basel
Basel
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions